RenBio uses their technology to deliver bio-blueprints by intramuscular injection to be read by muscle cells to produce disease-fighting antibodies in the patient’s own body
Renbio
Rachel Liberatore
Director of R&D
Renbio
Case Studies
Showing 2 Renbio Customer Success Stories
RenBio Reimagines Antibody Therapeutics with the Labstep ELN from STARLIMS
Renbio
Rachel Liberatore
President & Chief Scientific Officer
No matching case studies
